The MoCRA Beauty Accountability Report

The Modernization of Cosmetics Regulation Act has changed the operating meaning of beauty accountability in the United States. The result is a regulatory environment in which product information has become almost as important as the physical product itself.

The scale of that system is already substantial. Active MoCRA records include 16,398 cosmetic product facility registrations and 1,298,361 active cosmetic product listings. The facility population is split between 2,930 domestic registrations and 13,468 foreign registrations, meaning most of the registered manufacturing and processing footprint sits outside the United States. That international structure brings contract manufacturers, exporters, importers, private-label suppliers and global brand groups into the same accountability chain even when the consumer sees only one brand name on the package.

MoCRA also creates several compliance clocks that operate at different speeds. Product listings require annual updates. Serious adverse event reporting can operate on a 15-business-day timetable, and new qualifying information received within one year of the first serious event report can trigger another rapid submission.

This report follows that accountability system from registration and product listing through serious adverse event response, safety substantiation, records, manufacturing controls, digital submissions, domestic concentration and the international facility footprint. It then converts the evidence into a structured MoCRA Beauty Accountability Index, a 90-day implementation plan and an operating scorecard. It is whether the company can continuously show what is marketed, where it is made, who is responsible, why it is considered safe and how rapidly the organization can act when information changes. with clear ownership across every major regulatory compliance function.

Executive MoCRA Accountability Benchmarks

The numbers defining the new cosmetics compliance system

MoCRA's most visible statistics describe a regulatory network that is both large and data intensive. The 16,398 active facility registrations represent the manufacturing and processing layer, while the 1,298,361 active product listings represent the product layer. Dividing those two totals produces roughly 79 active product listings for every active facility registration.

The geographic split adds a second benchmark. Domestic facilities account for roughly 17.9% of the active registration total, while foreign facilities account for about 82.1%. The regulatory file has to bridge that distance.

The time requirements create a third benchmark. Facility renewal every two years rewards long-range calendar control. Annual product updates require more frequent portfolio reconciliation. Serious adverse event reporting requires rapid escalation within 15 business days.

These numbers also change the meaning of accountability for senior management. MoCRA therefore acts not only as a legal framework but also as a test of whether a beauty organization has mature product information and post-market safety systems.

 

 

Why Beauty Accountability Requires a System-Based Benchmark

A single phrase such as "MoCRA compliant" can hide very different levels of operational maturity. One company may have valid facility registrations but weak product reconciliation, while another may have excellent safety evidence but rely on a contract manufacturer whose facility information, batch records or change notifications are not consistently available.

System-based evaluation separates these dimensions. Identity comes first: the company needs to know which legal entities, facilities, products and responsible persons are involved. Product visibility comes next: every marketed cosmetic should be connected to the correct listing information and current formulation. Safety evidence adds another layer by showing why the product is considered safe under labeled or customary conditions.

The value of a system benchmark is that it reveals weak links between functions. MoCRA accountability depends on the handoffs among those teams. If the data do not meet in one controlled process, a time-sensitive event can become a search exercise at exactly the moment when the organization needs certainty.

A complete benchmark therefore asks two questions at the same time: is each required control present, and do the controls connect? The strongest system is one in which the product, facility, safety evidence, consumer signal and regulatory record remain linked throughout the commercial lifecycle.

 

The Scale of MoCRA Facility Registration

How large the regulated beauty production network has become

Active MoCRA registration data show 16,398 cosmetic product facilities in the current system. Of those, 2,930 are domestic and 13,468 are foreign. Registration is not concentrated only in familiar domestic manufacturing states; it reaches deeply into the international production network that supplies finished cosmetics, components, private-label programs and brand-owned products to the U.S. market.

The foreign share of roughly 82.1% means that cross-border accountability is not an edge case. In practice, this can require companies to maintain accurate names and addresses across different legal systems, coordinate with overseas facilities on changes, preserve contact routes that remain functional when staff move, and make sure the U.S.-facing regulatory record matches the facility that is actually manufacturing or processing the product.

Domestic facilities still form a substantial network of 2,930 registrations. Their challenges can be different. A domestic corporate group may operate multiple locations, use several contract manufacturers or shift production between states.

For accountability purposes, the registration count should be treated as a network map rather than a static total. The larger the network becomes, the more important standardized supplier onboarding, regulatory master data and renewal verification become.

 

Product Listing and the Scale of Cosmetic Visibility

Why 1.3 million active products change accountability

The product-listing side of MoCRA is much larger than the facility-registration side. Active data include 1,298,361 cosmetic product listings, a total that illustrates how quickly regulatory complexity expands once the system moves from manufacturing locations to individual products. Product-level visibility therefore requires a more granular operating model than facility registration alone.

The approximate ratio of 79 active product listings per active facility is useful because it shows the relative burden of product data. The ratio should not be interpreted as a literal average production load for each site. Instead, it highlights why product governance needs structured records.

Annual updating makes portfolio discipline especially important. Product discontinuations are common, and line extensions can multiply quickly. A better model performs recurring reconciliation between regulatory data, product information management, quality records and commercial status.

The million-plus listing total also changes how executives should view data quality. Product accountability is as much an information-architecture challenge as it is a filing requirement.

 

Facility Registration Renewal and Ongoing Accountability

Why registration is a recurring responsibility

Facility registration is not a permanent certificate that can be placed in a file and forgotten. Biennial renewal creates a predictable governance point for confirming that the facility still exists, that its identifying information remains accurate and that the company still understands its relationship to the products being manufactured or processed there.

The operational challenge is that two years is long enough for significant business change. Stronger programs maintain registration data continuously and use the renewal as a verification event rather than a reconstruction project.

Accountability improves when renewal dates are connected to a central compliance calendar and supplier review process. Domestic facilities should be managed with the same discipline, especially where corporate reorganizations or contract-manufacturing transitions can affect the record.

The practical goal is simple: at any point in the two-year cycle, the organization should be able to answer whether a facility is active, who owns the relationship, which products depend on it and when the next regulatory action is due. That turns registration from an administrative endpoint into a controlled lifecycle.

 

Annual Cosmetic Product Listing Updates

Product listings move on a faster rhythm than facility registrations. Responsible persons must provide updates annually, which creates a recurring requirement to compare the regulatory product universe with the products actually marketed. Seasonal launches, shade extensions, reformulations, limited editions, packaging changes and discontinued products can all create differences between commercial systems and regulatory records.

A disciplined annual process begins with portfolio reconciliation rather than form completion. Filing then becomes the final step in a broader data-quality exercise.

The annual rhythm also makes ownership important. Product development may know about formulation changes before regulatory affairs. Marketing may know about launch timing. Sales may know that a product is no longer carried.

MoCRA therefore creates a multi-speed compliance environment. Facilities operate on a two-year rhythm, product listings on an annual rhythm and safety reporting on an event-driven 15-business-day rhythm. Companies need systems that can manage all three without allowing the slower cycles to create complacency around the faster ones.

 

Serious Adverse Event Accountability

When beauty safety becomes a regulatory reporting issue

Serious adverse event reporting is one of the clearest examples of MoCRA changing cosmetics accountability from passive documentation to active post-market response. A responsible person must report qualifying serious adverse events associated with cosmetic use in the United States within 15 business days. That clock is short enough that a complaint cannot spend weeks moving through ordinary customer-service queues before someone with regulatory judgment sees it.

The operational challenge is classification. Customer service needs clear escalation triggers, and regulatory or safety staff need enough information to determine whether the event meets the serious threshold.

The serious outcomes include death, life-threatening experiences, inpatient hospitalization, persistent or significant disability or incapacity, congenital anomaly or birth defect, infection and significant disfigurement. These categories make documentation quality important because the seriousness decision can depend on medical details that are not captured in a standard product-return conversation.

Accountability continues after the first submission. If medical or other qualifying information is received within one year of the initial report, the responsible person must submit the new information within 15 business days. A mature program therefore has an intake clock, a submission clock and a continuing surveillance window.

 

What Counts as Serious in Cosmetic Safety

The difficulty of adverse-event governance lies in distinguishing the consumer experience from the regulatory seriousness of the outcome. Companies therefore need a triage framework that looks beyond complaint frequency and focuses on medical consequence.

The first level is ordinary customer preference. Comments about color, scent, texture, packaging or perceived performance usually belong in customer service and product quality channels. The next level is a product-quality complaint, such as a broken applicator, unusual odor or visible contamination concern.

High-priority events require rapid fact gathering. The goal is to create enough structure for a qualified person to make a timely seriousness assessment and prepare a complete report when required.

 

Safety Substantiation and Evidence Ownership

MoCRA places safety substantiation at the center of the responsible person's accountability. That evidence can draw from ingredient knowledge, formulation information, toxicological data, exposure considerations, product-use conditions, testing and other scientifically relevant material.

Beauty companies often operate through distributed evidence. If those elements cannot be linked to the marketed formulation, the organization can possess a large amount of information without having a coherent substantiation record.

Evidence ownership becomes particularly important when products change. This requires a different mindset from treating substantiation as a one-time document assembled at launch.

The most durable model is a living evidence file connected to the product master record. That makes safety substantiation part of product governance rather than a document that must be rediscovered when a regulator or serious complaint raises a question.

 

Records Access and Documentation Readiness

Records determine whether an organization can demonstrate what it knows. More broadly, accurate records allow companies to investigate complaints, trace production, verify product identity and defend decisions.

Three levels of readiness are useful. The first is availability: does the record exist at all? The second is traceability: can the record be connected to the correct product, formulation, facility, batch, supplier or event?

Beauty companies should therefore map records by accountability function. Facility records support registration and manufacturing identity. Product records support listings and formula history. Safety records support substantiation. Complaint files support post-market monitoring. Batch and quality records support investigations. Supplier records support traceability. Label files support responsible-person and consumer information.

 

Manufacturing Accountability and Cosmetic GMP

Why manufacturing controls move closer to the center

MoCRA directs FDA to establish cosmetic good manufacturing practice requirements, reinforcing a broader shift toward documented manufacturing accountability. The exact regulatory implementation continues to develop, but the operating principle is already clear: a beauty company needs confidence that products are made under controlled conditions and that the manufacturing record can explain what happened when quality or safety questions arise.

Manufacturing accountability begins with defined responsibilities and suitable facilities. These concepts are familiar in mature manufacturing systems, but MoCRA raises the importance of applying them consistently across a cosmetics supply chain that includes many small brands and contract manufacturers.

Contract manufacturing can create a governance gap when the brand assumes the factory owns every quality responsibility. Supplier agreements, quality agreements, audit rights and document expectations become part of regulatory accountability even when they are not themselves regulatory filings.

 

 

Fragrance Allergen Disclosure and Ingredient Transparency

Fragrance represents one of the most difficult transparency areas in cosmetics because consumers experience fragrance as a finished sensory concept while manufacturers manage it as a complex ingredient system. MoCRA requires FDA rulemaking around fragrance allergen labeling, placing additional pressure on brands to connect information held by fragrance houses and suppliers with the label information presented to consumers.

The accountability challenge is not simply adding words to a package. Proprietary fragrance composition can make this information chain more complicated, especially where the brand historically received only a generic fragrance declaration.

A mature approach treats fragrance data as structured product information. Supplier documentation should identify the information needed for regulatory evaluation, and change-control agreements should ensure that relevant changes are communicated before products are released. Regulatory and packaging teams should then verify that the consumer-facing label reflects the current approved formula and applicable requirements.

This is a useful example of why transparency and supply-chain governance are connected. The label can only be accurate when upstream information is complete enough for the responsible person to act on it.

 

Talc, Asbestos Testing and High-Scrutiny Product Categories

MoCRA also directs FDA to establish standardized testing methods for detecting and identifying asbestos in talc-containing cosmetic products. The policy significance goes beyond talc itself. It illustrates how high-scrutiny ingredients can shift accountability from general supplier assurances toward method-specific testing, sample control and laboratory documentation.

For a talc-containing product, a company needs confidence not only that testing occurred but also that the tested material can be connected to the material used in production. A certificate that cannot be linked to the relevant material lot provides less assurance than a controlled testing record embedded in the material-release process.

High-scrutiny categories also increase the importance of supplier qualification. Brands may need deeper visibility into raw-material sourcing, testing capability and change-control practices than they require for lower-risk inputs. Contract manufacturers should understand which materials require enhanced evidence and preserve the records needed to support later review.

 

Small-Business Exemptions and Their Limits

MoCRA contains exemptions for certain small businesses, but business size is not the only consideration. The existence of four specified carve-out categories means the product itself can change the result of the exemption analysis.

This is especially important in a fragmented beauty market where small brands often outsource manufacturing. The compliance assessment should therefore begin with the business criteria and then move to the actual products involved.

Documentation is part of the decision, and a determination made at launch should not be assumed to remain valid indefinitely.

 

 

Digital Compliance Infrastructure

Cosmetics Direct, structured submissions and regulatory data quality

MoCRA registration and listing depend increasingly on structured electronic information. The practical value of this infrastructure is validation and consistency, but it also means companies need reliable source data before they begin entering information.

Digital readiness is often underestimated. Companies should maintain controlled account administration, current contacts and documented submission procedures so staff changes do not interrupt access at a deadline.

Portal improvements also make renewal status more visible. These features can support stronger internal monitoring when companies use them as part of a compliance calendar rather than waiting for a reminder.

 

The 2024 Registration and Listing Transition

The first implementation period for mandatory facility registration and product listing showed how large the transition was for the cosmetics industry. FDA announced a six-month enforcement delay for the relevant registration and listing requirements, moving the enforcement date to July 1, 2024. The additional time recognized the practical challenge of bringing a large and diverse industry into a new mandatory data system.

That transition is useful context for the current environment. Early implementation naturally focused on getting facilities registered and products listed. As the system matures, accountability shifts toward maintaining accuracy. A record that was correct during initial onboarding can become stale as facilities change, products are discontinued, formulas are updated and company structures evolve.

The mature compliance question is therefore different from the launch-period question. Instead of asking whether the organization successfully completed the first wave of filings, leaders should ask whether the organization can keep those filings synchronized with the business every year and every renewal cycle. That requires routine governance, not project management alone.

 

U.S. State-Level Facility Concentration

Where domestic cosmetic manufacturing is concentrated

Domestic registration data show clear geographic concentration. Together, these five jurisdictions form the most visible domestic registration tier and reflect the combination of major consumer markets, beauty-company headquarters, contract-manufacturing capacity, logistics networks and established cosmetic production ecosystems.

California alone accounts for approximately 20.4% of the 2,930 domestic registered facilities. That concentration is significant because one state carries roughly one-fifth of the domestic footprint. Florida contributes about 12.0%, while Texas contributes about 8.0%.

The next tier includes Illinois with 112 facilities, North Carolina with 80, Ohio with 73, Pennsylvania with 69 and Colorado with 68. Regional contract manufacturers and specialty producers create a distributed system that can serve brands across the country.

 

Domestic Facility Concentration Beyond the Leaders

Below the largest states, the domestic registration pattern becomes a long tail. Numerous states fall in the 20-to-49 facility range, and many others have fewer than 20 active registrations. A brand can work with a small specialty manufacturer in a low-count state and face the same need for accurate registration, product records and safety accountability.

The long tail also complicates assumptions about supply-chain maturity. Registration count alone says nothing about the quality of an individual manufacturer; it only indicates the size of the local registered footprint.

Companies should use geographic data as a starting point for supplier mapping rather than supplier ranking. These controls matter equally in California and in a state with only a handful of registered facilities.

 

 

Global Facility Registration Footprint

Why MoCRA is effectively an international beauty accountability system

The 13,468 foreign facility registrations make MoCRA an international operating system for companies that want access to the U.S. cosmetics market. This structure reflects the globalized nature of beauty, where brands can be designed in one country, manufactured in another, packaged in a third and sold through U.S. retailers or online channels.

International accountability adds friction because information moves across company and national boundaries. Facility names may appear differently in local business records and U.S. regulatory systems. Contacts can change. Contract manufacturers may serve many brands.

The foreign data also show strong concentration. China alone accounts for 8,138 active facilities, dramatically more than any other country. South Korea has 947, India 568, Italy 328, Japan 301 and France 287.

 

China and the Scale of Beauty Manufacturing Accountability

China has 8,138 active registered cosmetic facilities, giving it an exceptional position in the MoCRA manufacturing landscape. That total represents roughly 60.4% of all foreign registrations and about 49.6% of all active facility registrations globally. In other words, nearly half of the current registered facility universe is associated with one country.

The scale is important because many U.S. beauty business models depend on Chinese contract manufacturing, packaging, accessories or finished cosmetic production. MoCRA accountability makes it increasingly important to know which physical site performs the manufacturing or processing activity and whether the regulatory record matches that site.

High concentration can also magnify data-quality problems. Quality and regulatory teams should therefore treat manufacturer changes as controlled events that trigger review of facility information, listings, product specifications, labels where relevant and supplier documentation.

 

South Korea, India, Japan and Asian Beauty Manufacturing

Outside China, Asia contains several major registered manufacturing centers. The pattern demonstrates that U.S.-bound cosmetics manufacturing is distributed across a wide Asian network rather than concentrated in one country alone.

South Korea's 947 facilities make it the second-largest foreign registration location in the dataset. India provides another large manufacturing base with 568 registered facilities, while Japan's 301 registrations reflect an established cosmetics and personal-care production environment.

Mid-sized locations such as Taiwan and Vietnam are also important because manufacturing relationships can shift as brands diversify suppliers. Facility verification, product-listing mapping, safety files and quality agreements need to be recreated or updated around the new manufacturing relationship.

 

 

European Beauty Manufacturing Under MoCRA

Europe forms another significant layer of the MoCRA facility network. Italy has 328 active registered facilities, France 287, Turkey 179, the United Kingdom 161, Spain 144 and Germany 107. Poland has 64 registrations and Switzerland 36. The pattern connects major European beauty, fragrance and personal-care manufacturing centers to the U.S. accountability system.

Italy and France stand out because both combine established luxury, fragrance and contract-manufacturing ecosystems with hundreds of registered facilities. Supplier sophistication, however, does not automatically transfer regulatory responsibility.

The European footprint also illustrates how multinational brands can operate through multiple regulatory regimes at the same time. Harmonization can reduce duplication, but market-specific obligations still need explicit ownership.

 

Canada, Mexico, Brazil and the Americas

The Western Hemisphere also contributes a substantial foreign facility footprint. Canada has 236 active registrations, Mexico 192, Brazil 189 and Colombia 124. The Dominican Republic has 45, Argentina 21 and Chile 15. These numbers create a meaningful regional layer between the very large Asian manufacturing base and smaller global supply nodes.

Canada and Mexico are particularly relevant because geographic proximity can make cross-border manufacturing feel operationally similar to domestic sourcing. From an accountability perspective, however, foreign registration status still matters. Companies need the correct facility record, import-related coordination and product mapping even when the manufacturing site is only a short distance from the U.S. border.

Brazil's 189 registrations and Colombia's 124 demonstrate that Latin American cosmetics manufacturing is also connected to the U.S. market at meaningful scale. Each new supplier relationship should enter the same regulatory and quality governance process used for larger manufacturing countries.

 

Pakistan and Smaller International Beauty Supply Nodes

Pakistan has 15 active registered cosmetic facilities in the dataset, placing it among the smaller international manufacturing nodes connected to MoCRA. These smaller counts are useful because they show how broadly the U.S. regulatory system reaches beyond the largest beauty-exporting countries.

A low national facility count should not be interpreted as low regulatory relevance for an individual brand. Accountability is determined by dependency and product exposure, not by national ranking alone.

Smaller manufacturing nodes can also create unique communication challenges. Brands should therefore define evidence expectations clearly at onboarding and verify that the supplier can support updates, complaint investigations and change notifications over time.

 

Foreign Versus Domestic Accountability Comparison

Domestic and foreign facilities participate in the same MoCRA framework, but the operational pathways to accountability can differ. Foreign supply chains add those same issues plus distance, time zones, language differences, import relationships and greater dependence on external partners for information.

The numerical gap is large. Domestic facilities total 2,930 while foreign facilities total 13,468. That means a beauty company designing its compliance program around domestic assumptions will miss the dominant structure of the actual registration system. Supplier governance needs to be treated as a core MoCRA capability, not an optional procurement activity.

Foreign manufacturing does not automatically create weaker compliance, just as domestic manufacturing does not automatically create stronger compliance. The deciding factor is visibility. A company with excellent foreign quality agreements, current records and reliable change notification can have stronger accountability than a company with a domestic facility whose product information is fragmented across departments.

 

 

The MoCRA Beauty Accountability Index

Converting compliance activity into a measurable operating standard

The MoCRA Beauty Accountability Index converts the report into eight weighted pillars totaling 100 points. Product Listing Accuracy receives 16%, the largest single weight, because the active product universe exceeds 1.29 million listings and annual updates require disciplined reconciliation. Safety Substantiation and Adverse Event Readiness each receive 15%, reflecting the importance of both pre-market evidence and rapid post-market response.

Facility Registration and Renewal receives 14%, capturing current registration, ownership, renewal controls and material changes. Governance and Supplier Accountability receive 7%, the smallest individual weight but a critical enabling layer for cross-functional and foreign-manufacturer coordination.

The index is designed to prevent one strong control from hiding another weak one. Sub-scores should remain visible so executives can see where the operating model is fragile.

 

 

The Biggest MoCRA Accountability Gaps

The most common accountability weakness is reducing MoCRA to registration and listing. In reality, the most consequential failures often appear elsewhere: a serious complaint is not escalated, safety evidence cannot be linked to the current formula, a foreign manufacturer changes without regulatory review or a marketed SKU remains disconnected from the correct listing record.

Fragmented ownership is another recurring risk. Product development may approve a reformulation without triggering a listing review. None of these failures requires negligence; they can emerge naturally when functions optimize their own workflows without a shared accountability map.

Technology can either reduce or amplify these gaps. The underlying risk comes from unmanaged complexity rather than company size alone.

 

90-Day MoCRA Beauty Accountability Plan

Days 1 to 30 should create visibility. The goal is to understand the real regulatory footprint before trying to improve it.

Days 31 to 60 should test the controls. A simulated serious adverse event is particularly valuable: start with a realistic consumer complaint and measure how long it takes to identify the product, gather the label, determine seriousness and prepare a regulatory-quality case file.

Days 61 to 90 should close gaps and build governance. Supplier onboarding should include registration and quality checks. Product change control should include a regulatory-impact review.

The 90-day plan is deliberately operational: Which facility makes this product? Is the listing current? Where is the safety basis? Who assesses a serious complaint? When is the next renewal?

 

 

Metrics Beauty Brands Should Track

Registration metrics should begin with coverage. Foreign and domestic facilities should be visible in the same dashboard so international relationships do not disappear into procurement systems.

Product metrics should track the active commercial portfolio against active listings. Because the system contains more than 1.29 million active listings, the benchmark should be completeness and alignment rather than the raw number of submissions completed.

Safety metrics should measure both volume and speed. Time from complaint intake to safety review, time from seriousness determination to submission and the number of open one-year follow-up cases reveal whether the reporting system can operate inside the 15-business-day window.

 

 

How MoCRA Accountability Changes by Business Model

Ingredient suppliers sit at the beginning of the evidence chain. Their accountability contribution is accurate ingredient identity, specifications, safety information and timely notification of changes. They may not own the finished-product listing, but their documentation can determine whether the manufacturer and responsible person can support safety substantiation or investigate a quality problem efficiently.

Contract manufacturers control much of the physical evidence. Private-label arrangements are especially sensitive because the brand can appear operationally distant from production while remaining central to the consumer-facing accountability chain.

Brand owners and responsible persons need the broadest view. Retailers do not replace the responsible person's obligations, but their supplier standards and complaint channels can influence how quickly safety information reaches the right company.

 

Beauty Accountability Maturity Model

A five-level maturity model helps translate the report into organizational development. Level 1 is reactive: the company addresses registration, listing or complaints when deadlines and problems appear. Level 2 is administrative: filings are completed, but regulatory work remains separate from product development, quality and customer service. These organizations can look compliant in routine periods while struggling during change or a serious event.

Level 3 is controlled. Responsibilities are documented, calendars exist, product and facility records are maintained and complaint escalation has defined triggers. Level 4 is integrated. Regulatory data connect to product systems, supplier governance, quality investigations and change control. Teams do not need to reconstruct relationships manually because the operating process already links them.

Level 5 is accountable. The organization continuously reconciles marketed products, facility status, safety evidence, complaints, labels and supplier changes. Management can view key metrics, test response capability and identify overdue actions before they become violations. The system is resilient to staff changes because knowledge is embedded in controlled records rather than individual memory.

 

 

The MoCRA Beauty Accountability Report FAQ

What is MoCRA?

The Modernization of Cosmetics Regulation Act of 2022 expanded FDA's cosmetics authorities and created new industry responsibilities around areas such as facility registration, product listing, serious adverse event reporting and safety substantiation. It also directs FDA rulemaking in areas including cosmetic GMP, fragrance allergen labeling and asbestos testing methods for talc-containing cosmetic products.

How many cosmetic facilities are actively registered?

The current active total is 16,398 facilities. The domestic portion is 2,930 and the foreign portion is 13,468, so approximately 82% of the registered facility footprint is outside the United States.

How many cosmetic product listings are active?

The active product-listing total is 1,298,361. That is roughly 79 active product listings for each active facility registration, illustrating how much larger the product-data layer is than the facility layer.

How often do cosmetic facilities renew registration?

Covered facilities operate on a biennial renewal cycle. Strong programs maintain facility information continuously so the two-year renewal becomes a confirmation process rather than a search for outdated data.

How often are cosmetic product listings updated?

Responsible persons must provide updates annually. The practical control is an annual reconciliation between the active commercial portfolio and the regulatory listing system, including products that have changed or been discontinued.

How quickly must serious adverse events be reported?

 Qualifying serious adverse events associated with cosmetic use in the United States must be reported within 15 business days. The reporting process should therefore begin with rapid complaint screening and defined escalation triggers.

Does serious-event responsibility end after the first report?

 No. If the responsible person receives new medical or other qualifying information about the event within one year of the initial report, the new information must be submitted within 15 business days.

Are small beauty businesses automatically exempt?

No. MoCRA provides exemptions for certain small businesses, but the relevant exemptions do not apply to specified categories of cosmetic products. Businesses should evaluate both the entity criteria and the actual products involved.

Why are foreign manufacturers so important under MoCRA?

 Foreign facilities account for about 82.1% of the active registered-facility total. China alone has 8,138 registered facilities, representing roughly 60.4% of the foreign total and nearly half of all active facility registrations.

What should a beauty company monitor first?

The first priorities are facility identity and renewal status, product-to-listing reconciliation, responsible-person ownership, safety substantiation, complaint escalation, serious-event timing, manufacturing records, supplier change control and regulatory access. These controls create the foundation for the broader accountability system.

Final Takeaway

MoCRA now operates across a cosmetics system with 16,398 active registered facilities and 1,298,361 active product listings. Companies need to manage a relatively concentrated facility network around a vastly larger product universe, and they need to keep both synchronized as portfolios, suppliers and business structures change.

 

The geographic picture makes accountability even more complex. Only 2,930 active facilities are domestic, while 13,468 are foreign. China alone accounts for 8,138 active registrations, and large secondary footprints appear in South Korea, India, Italy, Japan, France, Canada, Mexico, Brazil and other manufacturing markets. The U.S. cosmetics system is therefore dependent on regulatory data that move across borders and corporate boundaries.

 

The compliance clocks reinforce the need for disciplined systems. Facility registrations renew every two years. Product listings require annual updates. Serious adverse events can require action within 15 business days, and follow-up information received within a year can trigger another submission.

 

Modern beauty accountability means being able to identify what was made, where it was made, who is responsible, why it is considered safe, what happened when a consumer experienced a problem and which evidence supports every answer. The strongest system keeps products, facilities, safety information, supplier relationships and regulatory decisions continuously connected.